General
Preferred name
RUCAPARIB PHOSPHATE
Synonyms
AG-014699 ()
PF-01367338 ()
PF-01367338 phosphate ()
AG-014699 phosphate ()
AG 014699 ()
Rucaparib (phosphate) ()
AG-014699 (phosphate) ()
PF-01367338 (phosphate) ()
Rucaparib (AG-014699) phosphate ()
AG-14699 ()
AG014699 ()
PF01367338 ()
P&D ID
PD011140
CAS
459868-92-9
283173-50-2
Tags
available
drug candidate
Drug Status
investigational
Max Phase
Phase 1
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Rucaparib Phosphate is a selective PARP inhibitor that suppresses the PARP1-mediated DNA repair via binding to PARP1 (Ki = <5 nM). It can be used to sensitize cancer cells to chemotherapy as an antineoplastic agent. (BOC Sciences Bioactive Compounds)
Compound Sets
10
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Drugs
EU-OPENSCREEN Bioactive Compound Library
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Welcome Trust Cancer Drugs
External IDs
13
Properties
(calculated by RDKit )
Molecular Weight
421.12
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
6
Rotatable Bonds
3
Ring Count
4
Aromatic Ring Count
3
cLogP
2.05
TPSA
134.68
Fraction CSP3
0.21
Chiral centers
0.0
Largest ring
7.0
QED
0.36
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Genome integrity
Chromatin/Epigenetic
DNA Damage/DNA Repair
Cell Cycle/DNA Damage
Epigenetics
Target
PARP1, PARP2
PARP
PARP1 inhibitor
Source data